eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

THE BOOTS COMPANY PLC

1 Thane Road West, Beeston, Nottingham, NG2 3AA
Telephone: +44 (0)1159 595 165
Fax: +44 (0)1159 592 565

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 09/03/2011
SPC Boots Epsom Salts B.P.


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Epsom Salts (Magnesium Sulphate BP)

Boots Epsom Salts B.P.


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Magnesium Sulphate 100%


Go to top of the page
3. PHARMACEUTICAL FORM

Powder for oral solution


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the symptomatic relief of occasional constipation.


Go to top of the page
4.2 Posology and method of administration

Adults and children over 12 years: 1 to 4g to be taken in warm water, once daily.

Children under 12 years. Not recommended.


Go to top of the page
4.3 Contraindications

Intestinal obstruction.


Go to top of the page
4.4 Special warnings and precautions for use

To be used with caution in elderly or debilitated patients and in those with renal insufficiency.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

This product may interact with tetracyclines, digoxin, vitamins and iron and may potentiate tubocurarine during anaesthesia.


Go to top of the page
4.6 Pregnancy and lactation

The use of magnesium containing salts in the first trimester of pregnancy should be avoided.

They should only be used after medical advice if the benefits exceed potentially unknown risks of foetal exposure to magnesium. No adverse effects are anticipated in breast fed infants.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Prolonged excessive use of this product may cause alkalosis and hypermagnesaemia.


Go to top of the page
4.9 Overdose

Excessive amounts of this medicine may cause diarrhoea and dehydration. Hypermagnesaemia and hypercalcaemia may also occur, particularly if there is impaired renal function. Treatment consists of supportive and symptomatic measures with appropriate correction of fluid and electrolyte balance.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Not applicable.


Go to top of the page
5.2 Pharmacokinetic properties

Not applicable.


Go to top of the page
5.3 Preclinical safety data

Never undertaken by Abdine Limited. This product was granted a 'Licence as of Right' some 25 years ago.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

None.


Go to top of the page
6.2 Incompatibilities

None are recognised.


Go to top of the page
6.3 Shelf life

As packaged for sale: Three years

As reconstituted for use: One day

After first opening the container: One month


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C


Go to top of the page
6.5 Nature and contents of container

A spirally wound, varnished, cardboard tub with a press-fit lid or polypropylene jar and cap containing 100g, 150g, 200g, 250g, 300g or 500g.


Go to top of the page
6.6 Special precautions for disposal and other handling

Take from 1 to 4g in warm water.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Bell Sons & Co (Druggists) Ltd

Gifford House

Slaidburn Crescent

Southport

Merseyside PR9 9AL


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 03105/0068


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

12 February 1999


Go to top of the page
10. DATE OF REVISION OF THE TEXT

29th November 2010


Go to top of the page
11 DOSIMETRY

(IF APPLICABLE)


Go to top of the page
12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

(IF APPLICABLE)



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/24341/SPC/


Active Ingredients/Generics

 
   magnesium sulphate